7th December 2021 | Pharma Updates

LS approval for bill on pharma institutes, research

The Lok Sabha has passed a bill that tries to accords special status to six more institutes of pharmaceutical education and research as well as set up a council for these institutes.

Biocon starts its expansion in ME market

Biocon has started its expansion into the Middle East market with an out-licensing deal with Tabuk Pharmaceutical Manufacturing Co.

Eris Life jumps after joint venture with MJ Biopharm

Eris Lifesciences rose 4.05% to Rs 734.30 after the drug company said it has formed a joint venture with MJ Biopharm to foray into the Indian insulin market.

Needle-Free Injections Market is Growing at a Compound Annual Growth Rate of 14.15% during 2021- 2026

In Aug’21, PharmaJet and their partner Zydus Cadila declared the EUA from the DCGI for ZyCoV-D.

NPPA fixes ceiling prices of 2 injections

National Pharmaceutical Pricing Authority has fixed the ceiling prices of hydroxocobalamin injection and methylthioninium injection at Rs 9.91 and Rs 21.85 respectively.

Covishield present monthly production capacity 250-275 mn doses, Covaxin 50- 60 mn doses: Govt

Both drug companies have achieved approx 90% of present production capacity, Bharati Pravin Pawar, Minister of State for Health, said.

Sputnik Light may be available soon: RDIF

Russian Direct Investment Fund said it is cooperating drug regulators on the registration of Sputnik Light.